Design and synthesis of novel depsipeptide inhibitors of human rhinovirus 3C protease.

被引:0
|
作者
Marakovits, JT [1 ]
Webber, SE [1 ]
Dragovich, PS [1 ]
Prins, TJ [1 ]
Zhou, R [1 ]
Fuhrman, SA [1 ]
Patick, AK [1 ]
Ford, CE [1 ]
Brown, EL [1 ]
Meador, JW [1 ]
Worland, ST [1 ]
Matthews, DA [1 ]
Ferre, R [1 ]
机构
[1] Agouron Pharmaceut Inc, Med Chem, San Diego, CA 92121 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
281-MEDI
引用
收藏
页码:U1011 / U1011
页数:1
相关论文
共 50 条
  • [1] Homophthalimides are inhibitors of human rhinovirus 3C protease.
    Jungheim, LN
    Cohen, JD
    Wang, QM
    Johnson, RB
    Villarreal, EC
    Wakulchik, M
    Loncharich, RJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 274 - MEDI
  • [2] Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors
    Webber, SE
    Marakovits, JT
    Dragovich, PS
    Prins, TJ
    Zhou, R
    Fuhrman, SA
    Patick, AK
    Matthews, DA
    Lee, CA
    Srinivasan, B
    Moran, T
    Ford, CE
    Brothers, MA
    Harr, JEV
    Meador, JW
    Ferre, RA
    Worland, ST
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) : 2683 - 2686
  • [3] Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease
    Webber, SE
    Tikhe, J
    Worland, ST
    Fuhrman, SA
    Hendrickson, TF
    Matthews, DA
    Love, RA
    Patick, AK
    Meador, JW
    Ferre, RA
    Brown, EL
    DeLisle, DM
    Ford, CE
    Binford, SL
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (26) : 5072 - 5082
  • [4] Design, synthesis, and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease
    Venkatraman, S
    Kong, JS
    Nimkar, S
    Wang, QM
    Aubé, J
    Hanzlik, RP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (04) : 577 - 580
  • [5] Synthesis of glycopeptides potential inhibitors of human rhinovirus 3C Protease
    Danalev, L.
    Lubin-Germain, N.
    Uziel, J.
    Auge, J.
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 56 - 56
  • [6] Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease
    Kawatkar, S. P.
    Gagnon, M.
    Hoesch, V.
    Tiong-Yip, C.
    Johnson, K.
    Ek, M.
    Nilsson, E.
    Lister, T.
    Olsson, L.
    Patel, J.
    Yu, Q.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (14) : 3248 - 3252
  • [7] Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors
    Namoto, Kenji
    Sirockin, Finton
    Sellner, Holger
    Wiesmann, Christian
    Villard, Frederic
    Moreau, Robert J.
    Valeur, Eric
    Paulding, Stephanie C.
    Schleeger, Simone
    Schipp, Kathrin
    Loup, Joachim
    Andrews, Lori
    Swale, Ryann
    Robinson, Michael
    Farady, Christopher J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 906 - 909
  • [8] Synthesis and evaluation of tripeptidyl α-ketoamides as human rhinovirus 3C protease inhibitors
    Chen, SH
    Lamar, J
    Victor, F
    Snyder, N
    Johnson, R
    Heinz, BA
    Wakulchik, M
    Wang, QM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (20) : 3531 - 3536
  • [9] Human rhinovirus 3C protease inhibitors: recent developments
    Wang, QM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (09) : 1151 - 1156
  • [10] S-nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease
    Xian, M
    Wang, QM
    Chen, XC
    Wang, K
    Wang, PG
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (18) : 2097 - 2100